Park Heejun
College of Pharmacy, Duksung Women's University, 33, Samyangro 144-gil, Dobong-gu, Seoul 01369, Republic of Korea.
Pharmaceutics. 2024 Feb 21;16(3):302. doi: 10.3390/pharmaceutics16030302.
In this study, protein-loaded poly(lactic-co-glycolic acid) (PLGA) microspheres were prepared via supercritical fluid extraction of emulsion (SFEE) technology. To understand the correlation between process parameters and the main quality characteristics of PLGA microspheres, a comprehensive prior study on the influence of process variables on encapsulation efficiency (EE), initial drug burst release (IBR), morphology, surface property, and particle size distribution (PSD) was conducted within a wide process condition range of each unit process step, from the double-emulsion preparation step to the extraction step. Bovine serum albumin (BSA), a high-molecular weight-protein that is difficult to control the IBR and EE of PLGA microspheres with, was used as a model material. As double-emulsion manufacturing process parameters, the primary (W/O) and secondary emulsion (W/O/W) homogenization speed and secondary emulsification time were evaluated. In addition, the effect of the SFEE process parameters, including the pressure (70-160 bar), temperature (35-65 °C), stirring rate (50-1000 rpm), and flow rate of supercritical carbon dioxide, SC-CO (1-40 mL/min), on PLGA microsphere quality properties were also evaluated. An increase in the homogenization speed of the primary emulsion resulted in an increase in EE and a decrease in IBR. In contrast, increasing the secondary emulsification speed resulted in a decrease in EE and an increase in IBR along with a decrease in microsphere size. The insufficient secondary emulsification time resulted in excessive increases in particle size, and excessive durations resulted in decreased EE and increased IBR. Increasing the temperature and pressure of SFEE resulted in an overall increase in particle size, a decrease in EE, and an increase in IBR. It was observed that, at low stirring rates or SC-CO flow rates, there was an increase in particle size and SPAN value, while the EE decreased. Overall, when the EE of the prepared microspheres is low, a higher proportion of drugs is distributed on the external surface of the microspheres, resulting in a larger IBR. In conclusion, this study contributes to the scientific understanding of the influence of SFEE process variables on PLGA microspheres.
在本研究中,通过超临界流体乳液萃取(SFEE)技术制备了载蛋白聚乳酸-乙醇酸共聚物(PLGA)微球。为了解工艺参数与PLGA微球主要质量特性之间的相关性,在从双乳液制备步骤到萃取步骤的每个单元工艺步骤的广泛工艺条件范围内,对工艺变量对包封率(EE)、初始药物突释(IBR)、形态、表面性质和粒径分布(PSD)的影响进行了全面的前期研究。牛血清白蛋白(BSA)作为一种难以控制PLGA微球IBR和EE的高分子量蛋白质,被用作模型材料。作为双乳液制造工艺参数,评估了初级(水/油)和次级乳液(水/油/水)的均质速度以及次级乳化时间。此外,还评估了SFEE工艺参数,包括压力(70 - 160 bar)、温度(35 - 65 °C)、搅拌速率(50 - 1000 rpm)和超临界二氧化碳(SC-CO₂)流速(1 - 40 mL/min)对PLGA微球质量特性的影响。初级乳液均质速度的增加导致EE增加和IBR降低。相反,增加次级乳化速度导致EE降低、IBR增加以及微球尺寸减小。次级乳化时间不足导致粒径过度增加,而时间过长则导致EE降低和IBR增加。提高SFEE的温度和压力导致粒径总体增加、EE降低和IBR增加。观察到,在低搅拌速率或SC-CO₂流速下,粒径和SPAN值增加,而EE降低。总体而言,当制备的微球EE较低时,较高比例的药物分布在微球外表面,导致IBR较大。总之,本研究有助于科学理解SFEE工艺变量对PLGA微球的影响。